Five Oceans Advisors Buys 824 Shares of CVS Health Co. (NYSE:CVS)

Five Oceans Advisors boosted its holdings in shares of CVS Health Co. (NYSE:CVSGet Rating) by 15.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,310 shares of the pharmacy operator’s stock after buying an additional 824 shares during the period. Five Oceans Advisors’ holdings in CVS Health were worth $585,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Miracle Mile Advisors LLC increased its holdings in CVS Health by 30.0% during the 2nd quarter. Miracle Mile Advisors LLC now owns 21,582 shares of the pharmacy operator’s stock valued at $2,000,000 after purchasing an additional 4,983 shares during the period. Capital City Trust Co. FL raised its holdings in CVS Health by 4.6% in the 2nd quarter. Capital City Trust Co. FL now owns 32,000 shares of the pharmacy operator’s stock worth $2,966,000 after acquiring an additional 1,404 shares during the last quarter. Rosenberg Matthew Hamilton raised its holdings in CVS Health by 10.6% in the 2nd quarter. Rosenberg Matthew Hamilton now owns 1,834 shares of the pharmacy operator’s stock worth $172,000 after acquiring an additional 176 shares during the last quarter. Marino Stram & Associates LLC raised its holdings in CVS Health by 2.0% in the 2nd quarter. Marino Stram & Associates LLC now owns 6,501 shares of the pharmacy operator’s stock worth $602,000 after acquiring an additional 129 shares during the last quarter. Finally, Cordasco Financial Network raised its stake in CVS Health by 5.3% during the 2nd quarter. Cordasco Financial Network now owns 6,879 shares of the pharmacy operator’s stock valued at $637,000 after buying an additional 345 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling at CVS Health

In other CVS Health news, EVP Alan Lotvin sold 22,541 shares of the business’s stock in a transaction dated Thursday, August 4th. The shares were sold at an average price of $104.00, for a total value of $2,344,264.00. Following the transaction, the executive vice president now directly owns 109,183 shares in the company, valued at approximately $11,355,032. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, EVP Alan Lotvin sold 22,541 shares of the business’s stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $104.00, for a total value of $2,344,264.00. Following the sale, the executive vice president now directly owns 109,183 shares of the company’s stock, valued at approximately $11,355,032. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Thomas M. Moriarty sold 138,654 shares of the business’s stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the completion of the sale, the executive vice president now directly owns 626,273 shares in the company, valued at $59,495,935. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

CVS has been the subject of several analyst reports. Loop Capital initiated coverage on CVS Health in a research note on Thursday, June 16th. They issued a “buy” rating and a $120.00 price objective for the company. Tigress Financial increased their price objective on shares of CVS Health from $125.00 to $130.00 in a report on Wednesday, August 17th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of CVS Health from $113.00 to $120.00 in a research report on Thursday, August 4th. Evercore ISI increased their price objective on shares of CVS Health from $120.00 to $125.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 7th. Finally, Credit Suisse Group raised their target price on shares of CVS Health from $113.00 to $117.00 and gave the stock an “outperform” rating in a research report on Monday, August 8th. Four research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $117.59.

CVS Health Price Performance

CVS traded down $1.72 on Friday, reaching $98.11. 38,160 shares of the company’s stock were exchanged, compared to its average volume of 4,398,985. The stock has a market cap of $128.80 billion, a PE ratio of 16.23, a P/E/G ratio of 1.52 and a beta of 0.73. CVS Health Co. has a twelve month low of $81.78 and a twelve month high of $111.25. The stock’s fifty day moving average price is $100.14 and its 200-day moving average price is $99.28. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.91 and a quick ratio of 0.65.

CVS Health (NYSE:CVSGet Rating) last posted its quarterly earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $2.16 by $0.24. The firm had revenue of $80.64 billion for the quarter, compared to analyst estimates of $76.38 billion. CVS Health had a net margin of 2.65% and a return on equity of 15.19%. CVS Health’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.42 earnings per share. Sell-side analysts expect that CVS Health Co. will post 8.53 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 1st. Shareholders of record on Friday, October 21st will be issued a $0.55 dividend. The ex-dividend date is Thursday, October 20th. This represents a $2.20 annualized dividend and a yield of 2.24%. CVS Health’s payout ratio is 35.77%.

CVS Health Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Read More

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.